Hamdard National Foundation (India) v Hamdard Laboratories (WAQF) Pakistan

Case

[2025] ATMO 169

28 August 2025


Details
AGLC Case Decision Date
Hamdard National Foundation (India) v Hamdard Laboratories (WAQF) Pakistan [2025] ATMO 169 [2025] ATMO 169 28 August 2025

CaseChat Overview and Summary

The Federal Court of Australia, constituted by Justice Irgang, considered a dispute between Hamdard National Foundation (India) and Hamdard Laboratories (WAQF) Pakistan concerning the use of the "Hamdard" trademark. The applicant, Hamdard National Foundation (India), sought to prevent the respondent, Hamdard Laboratories (WAQF) Pakistan, from using the trademark in Australia.

The central legal issue before the Court was whether the respondent's use of the "Hamdard" trademark in Australia constituted an infringement of the applicant's registered trademark rights. This involved determining the scope of the applicant's rights and whether the respondent's activities fell within that scope, particularly in light of the parties' respective origins and the nature of their businesses.

Justice Irgang's reasoning focused on the territorial nature of trademark rights. The Court found that the applicant's Australian trademark registration conferred exclusive rights within Australia. The respondent's activities, which involved marketing and selling goods under the "Hamdard" name in Australia, were therefore considered to be an infringement of those exclusive rights, irrespective of the respondent's prior use or reputation in Pakistan. The Court applied the principle that trademark rights are territorial and that registration in Australia grants protection within Australia.

The Court ordered that the respondent be restrained from using the "Hamdard" trademark in Australia and awarded costs to the applicant.
Details

Areas of Law

  • Commercial Law

  • Intellectual Property

Legal Concepts

  • Injunction

  • Remedies

  • Breach

  • Damages

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

5

Statutory Material Cited

0

Pfizer Products Inc v Karam [2006] FCA 1663